YTEN - Yield10 Bioscience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.41
-0.01 (-0.70%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.42
Open1.42
Bid1.35 x 1000
Ask1.62 x 1000
Day's Range1.39 - 1.54
52 Week Range1.12 - 8.67
Volume184,663
Avg. Volume78,058
Market Cap14.116M
Beta (3Y Monthly)3.23
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire18 days ago

    Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, announced today that it has received a positive response from the USDA-APHIS’s Biotechnology Regulatory Services (BRS) confirming that its genome-edited Camelina sativa plant lines developed using CRISPR-Cas9 for increased oil content are not regulated articles under BRS regulations. This clarification of the regulatory status of the triple genome-edited Camelina plant lines accelerates the path to conducting field trials in the United States in 2019. The Company’s submission along with the USDA-APHIS BRS response is posted on the USDA’s website.

  • GlobeNewswire25 days ago

    Yield10 Bioscience to Present at the Ladenburg Thalmann 2018 Healthcare Conference  

    WOBURN, Mass., Sept. 25, 2018-- Yield10 Bioscience, Inc., a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, announced today that ...

  • GlobeNewswire29 days ago

    Yield10 Bioscience Grants Research License to Forage Genetics to Evaluate Novel Yield Traits in Sorghum

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today announced that it has granted a non-exclusive research license to Forage Genetics International, LLC, a subsidiary of Land O’Lakes, Inc., to evaluate five novel yield traits in forage sorghum. Under the license, Forage Genetics plans to conduct research with the novel traits within its sorghum development program as a strategy to improve biomass yields. The novel yield traits included in the research license agreement include C3003, a trait derived from algae, as well as four traits from Yield10's “GRAIN” platform, C4001, C4002, C4003 and C4029.

  • GlobeNewswirelast month

    Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 26th CAOCS Canadian Lipid and Bioresource Conference 2018

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced that Meghna Malik, Ph.D., Team Leader, will be presenting later today, September 10, at the Canadian Lipid and Bioresource Conference 2018 (CLBC2018), the Canadian Section of the American Oil Chemists’ Society (CAOCS). Dr. Malik’s presentation is titled “The Yield10 Bioscience Platform: Technologies for increasing seed yield and oil content in oilseeds.” The presentation is part of the Plant Lipid Metabolism and Biotechnology program which is scheduled from 1:30 to 2:50 pm local time. Dr. Malik will describe the various approaches Yield10 and its wholly owned subsidiary, Metabolix Oilseeds, are taking to increase seed yield and oil content in oil seed crops.

  • GlobeNewswirelast month

    Yield10 Bioscience Reports Promising Seed Yield Results for Novel Yield Trait C3004 in Growth Chamber Studies in Camelina

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced promising results for its novel yield trait C3004 in growth chamber studies conducted using its Camelina platform. Camelina plant lines containing C3004 grew vigorously, and the best lines produced increases in seed yield in a range of 26% to 65% as compared to control plants. Yield10 plans to conduct field tests of the C3004 trait in Camelina as part of its 2019 Field Test program in Canada.

  • GlobeNewswire2 months ago

    Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018

    WOBURN, Mass., Aug. 28, 2018-- Yield10 Bioscience, Inc., a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today announced ...

  • GlobeNewswire2 months ago

    Yield10 Bioscience Announces Second Quarter 2018 Financial Results

    WOBURN, Mass., Aug. 09, 2018-- Yield10 Bioscience, Inc., a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today reported financial ...

  • ACCESSWIRE2 months ago

    Yield10 Bioscience, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 4:30 PM Eastern ...

  • GlobeNewswire2 months ago

    Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced it has signed a non-exclusive research license agreement jointly with the Broad Institute of MIT and Harvard and Pioneer, part of Corteva AgriscienceTM  Agriculture Division of DowDuPont (DWDP), for the use of CRISPR-Cas9 genome-editing technology for crops. CRISPR technology is uniquely suited to agricultural applications as it enables precise changes to plant DNA without the use of foreign DNA to incorporate new traits. Recent public comments by USDA-APHIS indicate that plants developed using CRISPR genome-editing technology have the potential to be designated “non-regulated” by the agency for development and commercialization in the U.S., which could result in shorter timelines and lower costs associated with commercialization of new traits in the U.S. as compared to regulated crops.

  • GlobeNewswire3 months ago

    Yield10 Bioscience to Host Webcast of its Second Quarter 2018 Conference Call

    Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, announced today that the Company plans to release its second quarter 2018 financial results and host a conference call with management after market close on Thursday, August 9, 2018. The Company invites shareholders to submit questions for consideration by August 7, 2018 to IR@yield10bio.com with the subject line: “Questions for Second Quarter 2018 Call.” Questions submitted in advance of the call will be reviewed, and some will be addressed in management's prepared remarks or in the Q&A portion of the call. A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com.  The webcast will also be archived on the Company’s website in the investor relations section.

  • ACCESSWIRE4 months ago

    Venator Materials and Three Additional Specialty Chemicals Stocks on Our Research Desk’s Radar

    LONDON, UK / ACCESSWIRE / July 2, 2018 / If you want a free Stock Review on VNTR sign up now at www.wallstequities.com/registration. This Monday, WallStEquities.com has initiated reports coverage on the following Specialty Chemicals equities: Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN).

  • ACCESSWIRE5 months ago

    Yield10 Bioscience to Present at the 8th annual LD Micro Invitational

    WOBURN, MA / ACCESSWIRE / May 29, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN), a company focused on developing new technologies to achieve step-change improvements to crop yield to enhance global food ...

  • ACCESSWIRE5 months ago

    Free Pre-Market Technical Pulse on W.R. Grace and Three More Specialty Chemicals Stocks

    Today, WallStEquities.com takes a look at the recent performance of Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN). Stockton-On-Tees, the UK headquartered Venator Materials PLC's stock finished Thursday's session 0.27% lower at $18.37 with a total trading volume of 280,037 shares.

  • ACCESSWIRE5 months ago

    SeeThruEquity Issues Update on Yield10 Bioscience, Inc.

    NEW YORK, NY / ACCESSWIRE / May 23, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Yield10 Bioscience, Inc. (YTEN). Yield10 Bioscience (NASDAQ: YTEN, "Yield10") is an innovative agriculture bioscience company focused on the development and discovery of proprietary technologies to create a "step" increase in crop yield. With headquarters in Woburn, MA, and an oilseeds center in Saskatoon, Saskatchewan, Canada, the company has spent more than 15 years developing expertise in optimizing the flow of carbon in living systems, and is applying this extensive knowledge to designing precise alterations to gene activity designed to create a significant increase in yield for key crops including as canola, corn, soybean, and rice by as much as 10% - 20%.

  • ACCESSWIRE7 months ago

    Yield10 Bioscience to Present at The MicroCap Conference

    WOBURN, MA / ACCESSWIRE / April 3, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, ...